Zoetis, Inc. Investors: Company Investigated by the Portnoy Law Firm
12 avr. 2024 15h06 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 12, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zoetis, Inc. (“Zoetis”)...
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
11 avr. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
03 avr. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Fox Factory Holding Corp. (FOXF)
23 févr. 2024 13h38 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Fox Factory Holding Corp.
Robbins LLP Urges EAF Shareholders to Seek Legal Counsel Prior to the March 25 Lead Plaintiff Deadline
12 févr. 2024 13h22 HE
|
Robbins LLP
GrafTech International Ltd. (EAF) Misled Investors Regarding the Environmental Impact of its Business Operations
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
02 janv. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Jan. 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Announces Closing of a Private Placement
18 déc. 2023 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Announces Extension of Warrants
30 nov. 2023 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives
15 nov. 2023 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
DMTK SHAREHOLDERS: Contact Robbins LLP for Information Regarding the Class Action Against DermTech, Inc.
30 oct. 2023 18h19 HE
|
Robbins LLP
DermTech, Inc. (DMTK) Misled Investors Regarding its Business Prospects